Bruno Paquin
Chief Executive Officer at Centre For Probe Development & Commercialization
Network origin in Bruno Paquin first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Genizon Biosciences, Inc.
 Genizon Biosciences, Inc. BiotechnologyHealth Technology Genizon Biosciences Inc. discovers genes and biomarkers in common diseases using genome wide association studies (GWAS), leveraging its proven and proprietary technology platform and access to patients from the Quebec Founder Population. Genizon has one of the largest GWAS programs worldwide, addressing many common diseases and traits. Several of these have been successfully completed, generating comprehensive maps of interacting genes, biomarkers and biological disease pathways (known as GeneMaps), providing strong validation of the power of the Company's discovery platform. Genizon has out-licensed some of the therapeutic and diagnostic rights to GeneMaps for Crohn's disease (to Genentech) and attention deficit hyperactivity disorder, endometriosis and Alzheimer's disease (disease-state diagnostic rights to Pfizer). GeneMaps have also been generated from GWAS in schizophrenia, psoriasis and longevity. GWAS are in progress for rheumatoid arthritis, Alzheimer's disease, and coronary heart disease and its precursors, obesity, type II diabetes, dyslipidemia and hypertension (collectively metabolic syndrome). Genizon's technology platform and discoveries can complement current R&D programs by using human genetics to significantly enhance research and by adding value at multiple stages of the drug development process. Genizon is continually developing and enhancing its gene and biomarker discovery platform. For example, the company is assessing the role of copy number variations (CNVs) in diseases- applying new methods to ongoing large-scale GWAS in rheumatoid arthritis and metabolic syndrome, and retrospectively to previous studies. Genizon also leverages its platform and expertise by offering high throughput, high quality SNP genotyping, statistical genetics, gene expression and pharmacogenomics services to academic institutions, research organizations and the biopharmaceutical industry.
23
| Extinct | Biotechnology | 23 |
Centre For Probe Development & Commercialization
 Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin.
14
| Private Company | Pharmaceuticals: Major | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bruno Paquin via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AETERNA ZENTARIS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TELESTA THERAPEUTICS INC | Pharmaceuticals: Other | Director/Board Member | |
Horizon Sciences & Technologies, Inc.
 Horizon Sciences & Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Teva Pharmaceutical Industries Ltd., Horizon Sciences & Technologies, Inc. is a Canadian company that researches and develops pharmaceutical technology. The company is based in Montréal, Canada. | Miscellaneous Commercial Services | Director of Finance/CFO | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Montréal | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree Doctorate Degree | |
| McGill University | College/University | Masters Business Admin Graduate Degree Doctorate Degree | |
| FUSN PHAR | Pharmaceuticals: Major | Chairman Founder | |
| McMaster University | College/University | Undergraduate Degree Corporate Officer/Principal | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor Chief Investment Officer | |
Institut de recherches cliniques de Montréal
 Institut de recherches cliniques de Montréal Miscellaneous Commercial ServicesCommercial Services Institut de recherches cliniques de Montréal operates as an independent non-profit research institution focusing on biomedical research. The firm excels in basic research of economic development in the fields of pharmaceuticals, biotechnology and health services. The company was founded in 1967 and is headquartered in Montr?al, Canada. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Phoenix Molecular Designs Ltd.
 Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Toronto | College/University | Undergraduate Degree Masters Business Admin | |
Replicor, Inc.
 Replicor, Inc. Pharmaceuticals: OtherHealth Technology Replicor, Inc. operates as a biopharmaceutical company which develops and commercializes novel nucleic acid-based polymers. The company is headquartered in Montreal, Canada. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Unomedical A/S
 Unomedical A/S Medical SpecialtiesHealth Technology Unomedical A/S manufactures and distributes medical devices. It offers catheters, surgical aids, electrocardiography electrodes, general nursing products, drainage bags, wound care products, and infusion devices. The company is headquartered in Lejre, Denmark. | Medical Specialties | Director/Board Member | |
Diasend AB
 Diasend AB Packaged SoftwareTechnology Services Diasend AB provides communication platform between care providers and patients. Its system consolidates data from multiple glucose meters and insulin pumps into one single report, irrespective of device brand. The company was founded in 2004 and is headquartered in Askim, Sweden. | Packaged Software | Chairman | |
| Hammersmith Imanet Ltd. | Corporate Officer/Principal | ||
| Resolution Pharmaceuticals, Inc. | President | ||
| Chalmers University of Technology | College/University | Graduate Degree | |
| BACTIGUARD HOLDING AB | Medical Specialties | Director/Board Member | |
| University of Gothenburg | College/University | Undergraduate Degree | |
| Imperial College London | College/University | Doctorate Degree | |
Reapplix A/S
 Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Medical Distributors | Chairman | |
| RLS GLOBAL AB (PUBL) | Biotechnology | Chairman | |
Lumina Adhesives AB
 Lumina Adhesives AB Industrial SpecialtiesProcess Industries Lumina Adhesives AB provides switchable medical adhesive. It develops a Lumina Film dressing which consists of a thin polyurethane membrane, coated with a layer of switchable acrylic adhesive. It offers medical dressing that lose adhesion when exposed to visible light. The firm's products are used on fragile surfaces, including skin. The company was founded by Stefan Karl Wilhelm Svahn and Daniel Jacobsson in 2008 and is headquartered in Gothenburg, Sweden. | Industrial Specialties | Director/Board Member | |
Twinstrand Therapeutics, Inc.
 Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Apotek Produktion & Laboratorier AB
 Apotek Produktion & Laboratorier AB Pharmaceuticals: MajorHealth Technology Apotek Produktion & Laboratorier AB develops and manufactures pharmaceutical products. Its services include analytical services, clinical trials and contract manufacturing. The company is headquartered in Kungens Kurva, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal | |
| University of Quebec | College/University | Director/Board Member | |
PurGenesis Technologies, Inc.
 PurGenesis Technologies, Inc. Pharmaceuticals: MajorHealth Technology PurGenesis Technologies, Inc. develops and manufactures patented ingredients from natural sources. It offers anti-aging and sun care products for the cosmeceutical market. The firm develops prescription botanically-sourced therapeutics that address areas of unmet medical need. The company was founded by Purcell Marc in 1999 and is headquartered in Montmagny, Canada. | Pharmaceuticals: Major | Director of Finance/CFO | |
| APTILON CORPORATION | Advertising/Marketing Services | Director/Board Member |
Statistics
International
| Canada | 25 |
| Sweden | 10 |
| United Kingdom | 6 |
| Denmark | 4 |
| Finland | 2 |
Sectoral
| Health Technology | 16 |
| Consumer Services | 10 |
| Commercial Services | 9 |
| Process Industries | 3 |
| Finance | 3 |
Operational
| Director/Board Member | 157 |
| Corporate Officer/Principal | 53 |
| Independent Dir/Board Member | 45 |
| Chairman | 28 |
| President | 21 |
Most connected contacts
- Stock Market
- Insiders
- Bruno Paquin
- Company connections
